Publications by authors named "Peter Gottlieb"

Claim this Profile
G
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention.
Lu You, Hemang M Parikh, Taylor M Triolo, Lauric A Ferrat, Erin L Templeman, Peter A Gottlieb

Diabetes Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studies.
Erin L Templeman, Lauric A Ferrat, Hemang M Parikh, Lu You, Taylor M Triolo, Peter A Gottlieb

BMC Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials.
Daria Igudesman, Laura M Nally, Alyssa A Grimshaw, Craig G Gunderson, Elizabeth G Considine, Peter A Gottlieb

J Clin Endocrinol Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune Type 1 Diabetes in the Era of Disease-Modifying Immune Therapy.
Aaron W Michels, Peter A Gottlieb, Bryce Nelson, Colin Dayan

Diabetes Metab Res Rev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter.
Lauric A Ferrat, Erin L Templeman, Andrea K Steck, Hemang M Parikh, Lu You, Peter A Gottlieb

Diabetologia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Risk and Transition through Preclinical Stages of Type 1 Diabetes.
Andrea K Steck, Hemang M Parikh, Taylor M Triolo, Lauric Ferrat, Lu You, Peter A Gottlieb

J Clin Endocrinol Metab· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studies.
Erin L Templeman, Lauric A Ferrat, Hemang M Parikh, Lu You, Taylor M Triolo, Peter A Gottlieb

BMC Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel T-Cell Reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Individuals.
Anita C Hohenstein, Joylynn B Gallegos, Mylinh Dang, Jason Groegler, Hali Broncucia, Peter A Gottlieb

Diabetes· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes.
Catherine A Nicholas, Fatima A Tensun, Spencer A Evans, Kevin P Toole, Jessica E Prendergast, Peter A Gottlieb

Cell Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes.
Taylor M Triolo, Laura M Jacobsen, David Cuthbertson, Emily K Sims, Heba M Ismail, Peter A Gottlieb

Pediatr Diabetes· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives.
Taylor M Triolo, Hemang M Parikh, Mustafa Tosur, Lauric A Ferrat, Lu You, Peter A Gottlieb

J Clin Endocrinol Metab· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A type 1 diabetes prediction model has utility across multiple screening settings with recalibration.
Erin L Templeman, Lauric A Ferrat, Hemang M Parikh, Lu You, Taylor M Triolo, Peter A Gottlieb

Res Sq· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.
Morgan Sooy, Laura Pyle, Guy Todd Alonso, Hali C Broncucia, Arleta Rewers, Peter A Gottlieb

J Clin Endocrinol Metab· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
Laura M Jacobsen, David Cuthbertson, Brian N Bundy, Mark A Atkinson, Wayne Moore, Peter A Gottlieb

Diabetes Care· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islet-antigen reactive B cells display a unique phenotype and BCR repertoire in autoantibody positive and recent-onset type 1 diabetes patients.
Catherine A Nicholas, Fatima A Tensun, Spencer A Evans, Kevin P Toole, Hali Broncucia, Peter A Gottlieb

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Insulin-Chromogranin A Hybrid Peptide Activates DR11-Restricted T Cells in Human Type 1 Diabetes.
Aïsha Callebaut, Perrin Guyer, Rocky L Baker, Joylynn B Gallegos, Anita C Hohenstein, Peter A Gottlieb

Diabetes· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.
Peter N Taylor, Kimberly S Collins, Anna Lam, Stephen R Karpen, Brianna Greeno, Peter A Gottlieb

Lancet Diabetes Endocrinol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function.
Kevan C Herold, Stephen E Gitelman, Peter A Gottlieb, Laura A Knecht, Ralph Raymond

Diabetes Care· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review.
Laura M Jacobsen, Jennifer L Sherr, Elizabeth Considine, Angela Chen, Sarah M Peeling, Peter A Gottlieb

Commun Med (Lond)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
Deirdre K Tobias, Jordi Merino, Abrar Ahmad, Catherine Aiken, Jamie L Benham, Peter A Gottlieb

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an anergic BND cell-derived activated B cell population (BND2) in young-onset type 1 diabetes patients.
Zachary C Stensland, Christopher A Magera, Hali Broncucia, Brittany D Gomez, Nasha M Rios-Guzman, Peter A Gottlieb

J Exp Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring anti-islet autoimmunity in mouse and human by profiling peripheral blood antigen-specific CD4 T cells.
Siddhartha Sharma, Xuqian Tan, Josh Boyer, Don Clarke, Anne Costanzo, Peter Gottlieb

Sci Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Vitamin D in Management of Asthma: A Literature Review.
Charu Tibrewal, Naisargi Shrikant Modi, Parth S Bajoria, Prathma Anandbhai Dave, Ralph Kingsford Rohit, Peter Gottlieb

Cureus· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman, Peter A Gottlieb

Diabetes Care· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials.
Mara Kinney, Lu You, Emily K Sims, Diane Wherrett, Desmond Schatz, Peter A Gottlieb

J Endocr Soc· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis